Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment ; volume:19 ; number:1 ; day:17 ; month:9 ; year:2018 ; pages:1-6 ; date:12.2018
The journal of headache and pain ; 19, Heft 1 (17.9.2018), 1-6, 12.2018
- Urheber
-
Vikelis, Michail
- Beteiligte Personen und Organisationen
-
Argyriou, Andreas A.
Dermitzakis, Emmanouil V.
Spingos, Konstantinos C.
Makris, Nikolaos
Kararizou, Evangelia
SpringerLink (Online service)
- DOI
-
10.1186/s10194-018-0918-3
- URN
-
urn:nbn:de:101:1-2018110315362422572499
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vikelis, Michail
- Argyriou, Andreas A.
- Dermitzakis, Emmanouil V.
- Spingos, Konstantinos C.
- Makris, Nikolaos
- Kararizou, Evangelia
- SpringerLink (Online service)
Ähnliche Objekte (12)
The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine
Therapeutic novelties in migraine: new drugs, new hope?
Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
Therapeutic Benefits of Melatonin against COVID-19
Aquaporin 1, a potential therapeutic target for migraine with aura
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
Obsessive compulsive disorder and migraine: case report, diagnosis and therapeutic approach
ASK1 inhibition: a therapeutic strategy with multi-system benefits
Therapeutic benefits of lower limb prostheses: a systematic review
Migraine
A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain
Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo
The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine
Therapeutic novelties in migraine: new drugs, new hope?
Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
Therapeutic Benefits of Melatonin against COVID-19
Aquaporin 1, a potential therapeutic target for migraine with aura
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
Obsessive compulsive disorder and migraine: case report, diagnosis and therapeutic approach
ASK1 inhibition: a therapeutic strategy with multi-system benefits
Therapeutic benefits of lower limb prostheses: a systematic review
Migraine
A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain
Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo
The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine
Therapeutic novelties in migraine: new drugs, new hope?
Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
Therapeutic Benefits of Melatonin against COVID-19
Aquaporin 1, a potential therapeutic target for migraine with aura
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
Obsessive compulsive disorder and migraine: case report, diagnosis and therapeutic approach
ASK1 inhibition: a therapeutic strategy with multi-system benefits
Therapeutic benefits of lower limb prostheses: a systematic review
Migraine
A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain